
07/23/2025
Dr. Rachel Hopper, a pediatric cardiologist at Stanford Medicine Children's Health, is deeply committed to advancing clinical care and improving outcomes. Her dedication shines through her clinical practice, involvement in national organizations, and conferences where she shares her expertise. As the medical director of the Stanford Medicine Children’s Health Pulmonary Vascular Disease Program, Dr. Hopper focuses on helping children with pulmonary vascular disease and pulmonary hypertension.
Our Pulmonary Vascular Disease Program was established over 20 years ago as part of the Vera Moulton Wall Center for Pulmonary Vascular Disease at Stanford. It, is one of the nation's longest-standing and largest, providing care for hundreds of children from across the country and around the world.
With her extensive knowledge, Dr. Hopper also serves as co-director for the Cardiac and Respiratory Care for Infants with Bronchopulmonary Dysplasia (CRIB) Program and the Center for Advanced Lung (CEAL) Therapies. Our highly specialized CRIB Program gives premature infants with bronchopulmonary dysplasia their best chance at a lifetime of healthy breathing, even if they develop pulmonary hypertension (high blood pressure in the lungs) or have a congenital heart disease. CEAL offers hope to children with severe pulmonary hypertension or advanced lung disease, giving them the best chance at survival and an improved quality of life while awaiting lung transplants or other critical procedures.
Discover more about Dr. Hopper and the programs she’s most involved with at the Betty Irene Moore Children’s Heart Center: https://bit.ly/4dAAjAI